Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

A CRM1-mediated nuclear export signal governs cytoplasmic localization of BRCA2 and is essential for centrosomal localization of BRCA2

Abstract

Germ-line mutations of the BRCA2 gene cause inherited susceptibility to breast and ovarian cancers. BRCA2 contains two nuclear localization signals, predominantly localizes in the nucleus and plays significant roles in DNA double-strand break repair. Recently, we reported that BRCA2 localizes to the centrosomes during the S and early M phases of the cell cycle. In this study, for the first time, we identified a functional nuclear export sequence (NES1; 1383DLSDLTFLEVA1393) in BRCA2. The green fluorescent protein (GFP)-NES1 fusion protein was localized in the cytoplasm and could be blocked by the chromosomal region maintenance 1-specific export inhibitor leptomycin B. Mutation of a leucine residue in the NES1 motif to alanine (L1384A) resulted in both cytoplasmic and nuclear localization of the GFP-NES1 fusion protein and a nuclear accumulation of ectopic full-length BRCA2-FLAG. Moreover, treatment of cells with leptomycin B decreased centrosomal localization of BRCA2. Finally, by microinjection of an anti-BRCA2 antibody into the cytoplasm of HeLa S3 cells, we found that depletion of normal BRCA2 proteins in the cytoplasm leads to centrosome amplification and binucleated cells. Our results suggest that disruption of the NES function by genetic changes results in deregulation of BRCA2 export, which ultimately leads to centrosome disorder.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  • Bednenko J, Cingolani G, Gerace L . (2003). Nucleocytoplasmic transport: navigating the channel. Traffic 4: 127–135.

    Article  CAS  Google Scholar 

  • Daniels MJ, Wang Y, Lee M, Venkitaraman AR . (2004). Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2. Science 306: 876–879.

    Article  CAS  Google Scholar 

  • Esashi F, Christ N, Gannon J, Liu Y, Hunt T, Jasin M et al. (2005). CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature 434: 598–604.

    Article  CAS  Google Scholar 

  • Fabbro M, Henderson BR . (2003). Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Exp Cell Res 282: 59–69.

    Article  CAS  Google Scholar 

  • Fukuda M, Asano S, Nakamura T, Adachi M, Yoshida M, Yanagida M et al. (1997). CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 390: 308–311.

    Article  CAS  Google Scholar 

  • Gorlich D, Kutay U . (1999). Transport between the cell nucleus and the cytoplasm. Annu Rev Cell Dev Biol 15: 607–660.

    Article  CAS  Google Scholar 

  • Kudo N, Wolff B, Sekimoto T, Schreiner EP, Yoneda Y, Yanagida M et al. (1998). Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp Cell Res 242: 540–547.

    Article  CAS  Google Scholar 

  • Nakanishi A, Han X, Saito H, Taguchi K, Ohta Y, Imajoh-Ohmi S et al. (2007). Interference with BRCA2, which localizes to the centrosome during S and early M phase, leads to abnormal nuclear division. Biochem Biophys Res Commun 355: 34–40.

    Article  CAS  Google Scholar 

  • Spain BH, Larson CJ, Shihabuddin LS, Gage FH, Verma IM . (1999). Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations. Proc Natl Acad Sci USA 96: 13920–13925.

    Article  CAS  Google Scholar 

  • Taagepera S, McDonald D, Loeb JE, Whitaker LL, McElroy AK, Wang JY et al. (1998). Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. Proc Natl Acad Sci USA 95: 7457–7462.

    Article  CAS  Google Scholar 

  • Thompson ME, Robinson-Benion CL, Holt JT . (2005). An amino-terminal motif functions as a second nuclear export sequence in BRCA1. J Biol Chem 280: 21854–21857.

    Article  CAS  Google Scholar 

  • Tutt A, Gabriel A, Bertwistle D, Connor F, Paterson H, Peacock J et al. (1999). Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification. Curr Biol 9: 1107–1110.

    Article  CAS  Google Scholar 

  • Venkitaraman AR . (2002). Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108: 171–182.

    Article  CAS  Google Scholar 

  • Wang W, Budhu A, Forgues M, Wang XW . (2005). Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication. Nat Cell Biol 7: 823–830.

    Article  CAS  Google Scholar 

  • Weis K . (2003). Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle. Cell 112: 441–451.

    Article  CAS  Google Scholar 

  • Wong AK, Pero R, Ormonde PA, Tavtigian SV, Bartel PL . (1997). RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J Biol Chem 272: 31941–31944.

    Article  CAS  Google Scholar 

  • Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J et al. (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789–792.

    Article  CAS  Google Scholar 

  • Wu K, Hinson SR, Ohashi A, Farrugia D, Wendt P, Tavtigian SV et al. (2005). Functional evaluation and cancer risk assessment of BRCA2 unclassified variants. Cancer Res 65: 417–426.

    CAS  PubMed  Google Scholar 

  • Yang H, Li Q, Fan J, Holloman WK, Pavletich NP . (2005). The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA–ssDNA junction. Nature 433: 653–657.

    Article  CAS  Google Scholar 

  • Yano K, Morotomi K, Saito H, Kato M, Matsuo F, Miki Y . (2000). Nuclear localization signals of the BRCA2 protein. Biochem Biophys Res Commun 270: 171–175.

    Article  CAS  Google Scholar 

  • Zhang Y, Xiong Y . (2001). A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science 292: 1910–1915.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank all members of Department of Molecular Diagnosis of the Cancer Institute, Japanese Foundation for Cancer Research for helpful discussions and encouragement. Itaru Sakoh, Koki Miyamoto, Miki Fukuda at the Fujitsu co. are thanked for performing the microinjections. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Y Miki.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Han, X., Saito, H., Miki, Y. et al. A CRM1-mediated nuclear export signal governs cytoplasmic localization of BRCA2 and is essential for centrosomal localization of BRCA2. Oncogene 27, 2969–2977 (2008). https://doi.org/10.1038/sj.onc.1210968

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210968

Keywords

This article is cited by

Search

Quick links